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Abstract
Positive-strand RNA virus replication involves viral proteins and cellular proteins at nearly every replication step. Brome
mosaic virus (BMV) is a well-established model for dissecting virus-host interactions and is one of very few viruses whose
RNA replication, gene expression and encapsidation have been reproduced in the yeast Saccharomyces cerevisiae.
Previously, our laboratory identified ,100 non-essential host genes whose loss inhibited or enhanced BMV replication at
least 3-fold. However, our isolation of additional BMV-modulating host genes by classical genetics and other results
underscore that genes essential for cell growth also contribute to BMV RNA replication at a frequency that may be greater
than that of non-essential genes. To systematically identify novel, essential host genes affecting BMV RNA replication, we
tested a collection of ,900 yeast strains, each with a single essential gene promoter replaced by a doxycycline-repressible
promoter, allowing repression of gene expression by adding doxycycline to the growth medium. Using this strain array of
,81% of essential yeast genes, we identified 24 essential host genes whose depleted expression reproducibly inhibited or
enhanced BMV RNA replication. Relevant host genes are involved in ribosome biosynthesis, cell cycle regulation and protein
homeostasis, among other cellular processes. BMV 2a
Pol levels were significantly increased in strains depleted for a heat
shock protein (HSF1) or proteasome components (PRE1 and RPT6), suggesting these genes may affect BMV RNA replication
by directly or indirectly modulating 2a
Pol localization, post-translational modification or interacting partners. Investigating
the diverse functions of these newly identified essential host genes should advance our understanding of BMV-host
interactions and normal cellular pathways, and suggest new modes of virus control.
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Introduction
Viruses survive with limited genetic material by interacting with
and exploiting host factors at essentially every replication step
[1,2,3,4,5,6,7,8,9,10,11,12,13,14]. Identifying the host factors and
pathways exploited in virus replication and the nature of their
contributions and interactions with virus-encoded replication
factors represent major challenges and opportunities for under-
standing and controlling viruses.
Positive-strand RNA viruses comprise over one third of all virus
genera and include important human pathogens such as hepatitis
C virus, dengue virus, chikungunya virus, and West Nile virus
[15]. Brome mosaic virus (BMV), a member of the alphavirus-like
superfamily of human, plant, and animal viruses, has been used as
a model system to study gene expression, RNA replication and
virus-host interactions of positive-strand RNA viruses [1,2,8,
10,16]. BMV has three genomic RNAs and one subgenomic (sg)
mRNA. Genomic RNAs 1 and 2 encode the multifunctional repli-
cation proteins 1a and 2a polymerase (2a
Pol), respectively, which
are required for RNA replication [17,18,19]. Genomic RNA3
encodes the 3a movement protein, required for infection spread in
plants. A sg mRNA, RNA4, encodes the viral coat protein and is
produced from the (2)RNA3 replication intermediate. BMV RNA
replication and encapsidation can be recapitulated in the yeast
Saccharomyces cerevisiae by expressing the viral replication and/or
capsid proteins together with at least one genomic RNA template
[20,21,22]. The ability of BMV to duplicate nearly all major
replication features of its natural plant hosts in yeast, combined
with yeast genetics, has advanced our understanding of BMV
replication and virus-host interactions [1,2,9].
Previously, we tested deletions of nearly all non-essential yeast
genes (,80% of the yeast genome) and identified 99 genes, that
when deleted, altered BMV replication, revealing the involvement
of many novel host pathways in viral replication, transcription,
and translation [9]. However, classical yeast genetics and other
approaches have demonstrated that genes essential for cell growth
also make major contributions to BMV RNA replication [23,24,
25,26]. To more globally identify additional essential host factors
critical for BMV RNA replication, we assayed a doxycycline (dox)-
repressible library of ,900 yeast strains, each of which allows
repressing the expression of a selected essential gene by adding dox
to growth media [27]. Using this genome-wide approach, we
identified 24 essential host factors whose repressed expression
reproducibly altered BMV RNA replication. These host factors
are involved in protein homeostasis, protein trafficking, and
translation,amongothers.Theresultspresented here,inconjunction
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more complete understanding of cellular pathways utilized by
BMV. Dissecting the role of these essential host genes in virus
replication should significantly advance our understanding of basic
virus biology and virus-host interactions. Additionally, these results
may lay a foundation for extending such studies to other virus
groups, thus potentially identifying common cellular pathways
that could be targeted for the development of broad-spectrum
antivirals.
Methods
S. cerevisiae Strains and Plasmids
The yeast Tet-Promoter Hughes Collection of essential yeast
strains was purchased from Open Biosystems (Huntsville, AL).
The tet-promoter mutant strains (designated here with the prefix
PTET) were provided in the haploid R1158 background (MATa
URA3::CMV-tTA MATa his3-1 leu2-0 met15-0), which was con-
structed by a one-step integration of the cytomegalovirus (CMV)
promoter-driven tTA* transactivator at the URA3 locus [28]. The
kanR-tetO7-TATA was then integrated into the promoter of a
different essential gene in strain R1158, allowing the repression of
essential gene expression upon the addition of dox to growth
medium [27].
pB12VG1 expresses BMV 1a and 2a
Pol from the GAL1 and
GAL10 promoters, respectively [9]. pB3BG29, based on pB3Rluc
[9], uses a truncated GAL1 promoter (GALL [29]) to express
RNA3 with the coat protein ORF replaced by the Renilla luciferase
(Rluc) ORF (from pRL-null; Promega, Madison, WI). pB3BG29
also expresses the firefly luciferase (Fluc) ORF (from pGL3-Basic;
Promega, Madison, WI) from the GAL10 promoter. To construct
pB3BG29, the AgeI-AatII RNA3/Rluc-containing fragment of
pB3Rluc [9] replaced the AgeI-AatII FHV RNA1/Rluc-containing
fragment of pBDL250-Ren [B. Lindenbach, unpublished].
pB3MS82 expresses a BMV RNA3 derivative in which the coat
protein gene has a four-nucleotide insertion and a point mutation,
abolishing expression of the coat protein [30]. The use of pB3MS82
in this study, as in many other studies [8,19,30,31,32,33], allows
analysis of RNA3 and RNA4 levels while avoiding any possible
effects of coat protein expression and RNA encapsidation.
pB12VG1 and pB3BG29 were used in reporter gene-based primary
screens and pB12VG1 and pB3MS82 were used in secondary
validation testing by Northern blotting.
Yeast transformation and growth
96-well yeast transformations were based on a one-step
procedure [34]. The PTET essential yeast strains were grown to
saturation overnight at 30uC in 96-well plates (1 ml per well). The
cells were pelleted, suspended in 100 ml of transformation mix
(0.18 M LiAc, pH 5.5, 36% polyethylene glycol-3350, 90 mM
DTT, 0.5 mg/ml sheared salmon sperm DNA, and 20 mg/ml of
each plasmid) per well and incubated at 30uC for 60 min. Cells
then were heat shocked at 42uC for 20 min, pelleted, re-suspended
in 20 ml sterile water per well and 10 ml was plated on solid media.
Transformants were selected by complementation of auxotrophic
markers. 96-well plates of transformed yeast were re-formatted to
contain 48 strains in duplicate per plate so that strains could be
analyzed in the absence of dox (allowing essential gene expression)
or in the presence of dox (repressing essential gene expression).
Strains containing BMV expression plasmids were grown over-
night in medium containing raffinose, subcultured to a starting
OD600=0.1 in medium containing raffinose 610 mg/ml dox,
grown for 24 hr subcultured to a starting OD600=0.1 in medium
containing galactose 610 mg/ml dox. Cells were analyzed at 24 hr
and 48 hr post gal-induction of virus expression. Strains were
grown in 96-well plates for luciferase assays and 14 ml culture
tubes for Northern analysis.
RNA Analysis
For 96-well Fluc assays, 2.5 ml of cells were lysed in 16Passive
Lysis Buffer (Promega, Madison, WI), 25 ml of Luciferase Assay
Substrate (Promega, Madison, WI) was injected and read for 1 s
with a 1.6 s delay using a VictorV (PerkinElmer, Waltham, MA).
For 96-well Rluc assays, 5 ml of cells were lysed in 16 Passive
Lysis Buffer, 25 mlo fRenilla Luciferase Assay Substrate
(Promega, Madison, WI) was injected and read for 1 s with a
1.6 s delay using a VictorV. To allow comparison between
plates, the median of untreated samples and the median of dox-
treated samples were calculated for each plate. Each untreated
sample was then normalized to the untreated median whereas
each dox-treated sample was normalized to the dox-treated
median. For each pass of the 741 PTET strains, we calculated
BMV-directed Rluc expression as [Rlucdox-treated/Flucdox-treated]
normalized to the dox-treated median and [Rlucuntreated/
Flucuntreated] normalized to the untreated median. The dox-
treated to untreated ratio of ratios was calculated and converted
to fold change. High-throughput isolation of total RNA from
yeast cells was performed as previously described [35]. Northern
blotting was performed as previously described [36] except that
2 mg RNA was separated in 1% (wt/vol) agarose-MOPS
(morpholinepropanesulfonic acid)-formaldehyde gels. RNAs
were detected using
32P-labeled probes specific for positive- or
negative-strand BMV RNA3 and RNA4 as previously described
[24]. The 18S rRNA probe was derived from pTRI RNA 18S
templates (Ambion, Austin, TX). Probes were synthesized using
an Epicenter Riboscribe probe synthesis kit (Madison, WI) with
the appropriate enzyme, i.e., T7 or or SP6 polymerase. Northern
blots were imaged on a Typhoon 9200 instrument (Amersham
Biosciences, Piscataway, NJ) and band intensities were analyzed
with ImageQuant software (Molecular Dynamics, Piscataway,
NJ).
Protein extraction, Western blotting, and total protein
analysis
Total protein was extracted as previously described [24] and
equal volumes of cell lysates were separated on 4–15%
Criterion
TM TGX
TM precast polyacrylamide gels (Bio-Rad,
Hercules, CA). Proteins were transferred to PVDF membrane
and expression of target proteins was detected with the following
antibodies and dilutions: rabbit anti-BMV 1a at 1:10,000, mouse
anti-BMV 2a
Pol at 1:3,000, and mouse anti-Pgk1p (Molecular
Probes, Carlsbad, CA) at 1:10,000 using HRP-conjugated
secondary antibodies (Thermo Scientific, Rockford, IL) and
Supersignal West Femto substrate (Thermo Scientific, Rockford,
IL).
Statistical analysis
The tools in R statistical package (version R-2.11.1) (http://
www.r-project.org/) [37] was used for statistical analysis of BMV
RNA replication data obtained by Northern blotting. Log
transformation was applied to [RNA4/18S rRNA]dox-treated/
[RNA4/18S rRNA]untreated ratios from Northern blot data, where
18S rRNA served as normalization standard. One-sided t-statistics
were used to identify the dox-treated strains whose RNA
replication was statistically significantly altered compared to
untreated strains. p-values from t-statistics were converted to q-
values to control for false discovery rate [37].
Essential Genes and BMV RNA Replication
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Identification of Essential Host Genes Affecting BMV RNA
Replication
To systematically identify novel, essential host genes affecting
BMV RNA replication, we screened a dox-repressible library of
essential yeast strains [27]. This collection contains ,900 yeast
strains, each with a single endogenous essential gene promoter
replaced by a tetracycline-repressible promoter [27]. Upon the
addition of the tetracycline derivative dox to growth media,
expression of the essential gene is repressed, and the protein
depleted. This library was used to identify changes in BMV RNA
replication after repression (dox-treated) relative to continuous
expression (untreated) of a specific essential host gene.
To assess the role of essential genes in BMV RNA replication,
we co-transformed each of the ,900 strains with BMV expression
plasmids pB12VG1 and pB3BG29 (Fig. 1A). pB12VG1 expresses
BMV RNA replication proteins 1a and 2a
Pol [9]. pB3BG29
expresses an Rluc reporter-expressing BMV RNA3 cDNA deriva-
tive and, as an expression control, the Fluc reporter gene (Fig. 1A).
DNA-dependent transcription produces an initial (+)RNA3
transcript that serves as a template for 1a- and 2a
Pol-dependent
RNA3 replication and sgRNA4 synthesis via a (2)RNA3
intermediate (Fig. 1A). Because sgRNA4, which encodes the coat
protein, is derived from the (2)RNA3 intermediate, its synthesis
depends on, and can serve as a reporter for, BMV RNA replica-
tion [20]. Accordingly, in pB3BG29 we replaced the coat protein
ORF with the Rluc reporter gene, so that luciferase assays could
be used as a rapid measure of RNA4 production and expression
(Fig. 1A). A similar approach was used for primary screening of the
yeast non-essential gene deletion library [9]. Of the 892 dox-
repressible strains transformed, 151 did not produce colonies after
repeated transformation attempts (Table S1), suggesting that the
transformation process or expression of the viral constructs
significantly impacted the fitness of these strains.
The remaining 741 transformants were re-formatted on 96-well
plates such that duplicates of each strain were present on the same
plate (Fig. 1B), allowing untreated and dox-treated strains to be
directly compared for changes in RNA replication. It is important
to note for this library that expression levels from the substituted
TET promoter are often different than expression levels from the
endogenous gene promoter [27]. Therefore, to test and to control
for possible changes in viral RNA replication and/or gene
expression, each treated strain was compared to its untreated
counterpart rather than to the parental wild type strain. Strains
were grown in raffinose-containing selective medium lacking dox
(allowing essential gene expression) or raffinose-containing selec-
tive medium containing 10 mg/ml dox (repressing essential gene
expression) for 24 hr to allow for initial depletion of the essential
gene mRNA and protein turnover in strains treated with dox.
After this 24 hr treatment period, strains were sub-cultured into
galactose-containing selective medium 610 mg/ml dox to induce
the expression of BMV components and subsequent viral RNA
replication in the continued expression (untreated) or repression
(dox-treated) of essential host factors. At 24 hr and 48 hr post-
virus induction, Rluc expression was measured as a readout of
BMV RNA3 replication and sgRNA4 synthesis. Because of
expected differences in the kinetics of gene product depletion
and their specific and non-specific effects on cell growth and BMV
RNA replication, we measured Rluc at 24 hr and 48 hr post-virus
induction for every strain. To monitor any potential adverse effects
of dox on the viability of these yeast strains and to ensure that GAL
promoter induction was effective, GAL driven Fluc expression,
which is independent of BMV RNA replication (Fig. 1A), was also
assayed at 24 hr and 48 hr post-virus induction (Fig. 1B). Two
independent analyses of the entire library were performed.
Since ,70% of the strains in this library exhibit growth defects
in the presence of dox (,20% of which exhibit growth defects
even in the absence of dox, presumably as a result of endogenous
promoter replacement) [27] and because BMV RNA replication
levels are often non-specifically enhanced in slow-growing cells,
stringent growth requirements were employed to minimize false
positives. Additionally, because we expected some strains to
exhibit either immediate dox-induced growth defects and/or
transcriptional defects from the GAL promoter, Fluc values in
untreated vs. dox-treated strains were closely monitored. Accord-
ingly, to be included in the final data analysis for potentially
specific effects on BMV replication, each strain was required to: 1)
double at least twice between 0–24 hr in galactose-containing
media; 2) double at least one additional time between 24–48 hr
in galactose-containing media; 3) and have an Flucdox-treated
value within 20% of its Flucuntreated value. As a reference, wild
type strain R1158 doubled 3 times between 0–24 hr and 2
times between 24–48 hr and had comparable Flucuntreated and
Flucdox-treated values. Strains that did not meet these growth or
Fluc value requirements in both passes were excluded from further
analysis (Tables S2 and S3). The remaining strains that satisfied
these growth and Fluc requirements and were included in analysis
(Table S4) showed .90% overlap between pass 1 and 2 at the
24 hr time point and .80% overlap between passes at the 48 hr
time point, confirming good reproducibility of screen conditions
(e.g. growth, dox-treatment, etc.) and assay performance.
From the analyzed strains (Table S4), we identified 42 essential
yeast genes that, when dox-depleted, altered BMV-directed Rluc
expression at least 6-fold in both passes at the same time point
(Tables 1 and 2). A more stringent 6-fold cutoff was used in the
primary screen in response to our observation that some strains in
this essential gene library showed more luciferase assay variability
than in our previous screen of non-essential genes. This increased
variability is likely due to the fact that these genes are essential for
cell growth. Thus, upon dox-induced repression of these genes, the
experiment is a race between specific effects of the relevant gene
on virus replication and the nonspecific, general suppression of cell
growth and viability that eventually occur with each strain.
Therefore, the results are more subject to variations due to small
changes in growth conditions or timing of the experiments.
Accordingly, a 6-fold cutoff was employed to limit the inclusion of
false positives.
In principle, altered BMV-directed Rluc expression observed in
the 42 candidate genes might result from general defects in RNA4
translation or viral RNA synthesis, or from selective defects in
replication, expression or function of the Rluc reporter gene. To
identify genes that specifically affected BMV RNA synthesis and/
or accumulation, secondary validation testing of the 42 candidate
genes was performed using Northern blotting to analyze RNA3
replication and RNA4 production, as described in the next two
sections.
Dox-repression of 19 essential genes facilitated BMV RNA
accumulation
Of the 42 candidate genes identified in the reporter gene-based
primary screens, 23 were genes whose repression enhanced BMV-
directed Rluc expression relative to Fluc expression at least 6-fold
in both passes at the same time point (Table 1). For secondary
validation tests, these 42 candidate strains were transformed with
the 1a- and 2a
Pol-expressing plasmid pB12VG1 and with a
plasmid expressing RNA3 retaining the BMV coat protein ORF
(Fig. 1A, pB3MS82). The levels of RNA3 and RNA4 replication
Essential Genes and BMV RNA Replication
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factors affecting BMV RNA replication. (A) BMV expression
plasmids. pB12VG1 expresses replication factors 1a and 2a
Pol. pB3BG29
expresses Fluc and RNA3. BMV-specific RNA-dependent RNA replication
and subgenomic mRNA synthesis is initiated from a cDNA derivative of
RNA3. DNA-dependent transcription produces an initial (+)RNA3
transcript that serves as a template for 1a- and 2a
Pol-dependent RNA3
replication and sgRNA4 synthesis via a (2)RNA3 intermediate. X, the
BMV coat protein gene or any gene replacing it, such as Rluc (used
here); GAL1/GAL10, yeast promoters, Rz, self-cleaving ribozyme. (B) 892
yeast strains, each with a single essential gene promoter replaced by a
doxycycline (dox)-repressible promoter, were transformed with BMV
expression plasmids. White wells indicate strains that did not transform.
Transformants were re-formatted on 96-well plates with duplicates of
each strain present on the same plate, allowing untreated and dox-
treated strains to be directly compared. Strains were grown in raffinose-
containing selective medium lacking dox (allowing essential gene
expression) or containing 10 mg/ml dox (repressing essential gene
expression) for 24 hr to allow for initial depletion of the essential gene
mRNA and protein turnover in dox-treated strains. After this 24 hr
treatment, strains were sub-cultured into galactose-containing selective
medium 610 mg/ml dox to induce expression of BMV components and
subsequent viral RNA replication. Viral RNA replication was quantitated
with a chemiluminescent Renilla luciferase assay at 24 hr and 48 hr
post-virus induction. Cell viability and promoter launching were
monitored with a chemiluminescent firefly luciferase assay at 24 hr
and 48 hr post-virus induction. Two independent analyses of the library
were performed.
doi:10.1371/journal.pone.0023988.g001
Table 1. Genes whose repression was associated with $6-
fold enhanced BMV-directed Rluc expression in both primary
screen passes.
Fold increase in Rluc expression
ORF Gene Pass 1 Pass 2
YLR359W ADE13 46 57
YBR070C ALG14 11 14
YDL132W CDC53 8.4 6.3
YOR204W DED1 180 140
YKL078W DHR2 8.3 8.0
YLR129W DIP2 440 160
YMR128W ECM16 12 7.4
YLR274W MCM5 33 19
YGR103W NOP7 46 78
YGR119C NUP57 30 19
YOR122C PFY1 7.9 7.5
YLR196W PWP1 11 28
YOL094C RFC4 21 14
YNL207W RIO2
a 16 12
YGL044C RNA15 41 12
YOR340C RPA43 17 6.3
YKR008W RSC4 250 310
YPL124W SPC29 13 10
YGR116W SPT6 45 17
YKL018W SWD2 48 9.1
YDR324C UTP4 12 11
YJL069C UTP18 11 50
YGR251W N/A
b 33 150
aRIO2 was identified at the 24 hr time point and all other genes were identified
at the 48 hr time point.
bORF not annotated in Saccharomyces Genome Database.
doi:10.1371/journal.pone.0023988.t001
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we used the level of RNA4 relative to 18S rRNA as the primary
measure of any dox-induced change in BMV RNA-dependent
RNA synthesis, through the ratio [RNA4/18S rRNA]dox-treated/
[RNA4/18S rRNA]untreated. RNA4 was used as the primary
measure of BMV RNA synthesis since, unlike RNA3, RNA4 is
only produced by viral RNA-dependent RNA synthesis and not
also by DNA-dependent transcription (Fig. 1A). Moreover, RNA4
level is the parameter most closely related to the Rluc expression
measured in the primary screen (Fig. 1A).
A statisticallysignificantincreaseinBMV(+)RNA4accumulation
relative to 18S rRNA was confirmed for 19 of the 23 genes (,83%
confirmation) at the commonly applied false discovery rate of 5%
(Fig. 2 and Table 3). False discovery rate analysis is a robust
statistical method that controls for multiple test variables by
calculating an adjusted, more stringent p-value, termed a q-value
[37]. (+)RNA4 levels were enhanced 1.5- to 8-fold in the 19
confirmed strains (Fig. 2 and Table 3).Similarly, levels of (2)RNA3,
the replication intermediate that serves as a template for sgRNA4,
were increased 1.4- to 5-fold in these strains (Table S5).
The 19 confirmed dox-repressed genes that enhanced BMV
RNAaccumulationencodeproteinswith functionsinvariedcellular
processes, including ribosome biosynthesis (DHR2, ECM16, NOP7,
PWP1, RIO2, RPA43, UTP4, UTP18, and YGR251w), cell cycle/
DNA maintenance (ADE13 and SPC29), mRNA metabolism
(RNA15, SPT6, and SWD2), protein homeostasis (PFY1), translation
(DED1), trafficking (NUP57) and lipid synthesis (ALG14) (Table 4).
Possible relations of these functions to viral replication are
considered further in the Discussion.
Dox-repression of five essential genes inhibited BMV RNA
accumulation
The primary screens additionally identified 19 essential host
genes that inhibited BMV-directed Rluc expression at least 6-fold
in both passes at the same time point (Table 2). Northern blotting
confirmed statistically significant decreases in BMV (+)RNA4
accumulation for 5 of 19 genes (,26% confirmation) at a false
Table 2. Genes whose repression was associated with $6-
fold inhibited BMV-directed Rluc expression in both primary
screen passes.
FolddecreaseinRlucexpression
ORF Gene Pass 1 Pass 2
YKL112W ABF1 15 9.1
YER168C CCA1 7.7 7.6
YFR028C CDC14
a 12; 9.2 6.0; 7.8
YNR038W DBP6 26 9.9
YPL266W DIM1 36 70
YDR141C DOP1 6.2 46
YJR017C ESS1 22 22
YOL133W HRT1 7.2 6.2
YGL073W HSF1
b 37 17
YGL018C JAC1 15 45
YAL033W POP5 17 12
YER012W PRE1
a 21; 8.4 13; 19
YML046W PRP39 9.4 49
YGL048C RPT6 15 52
YKL125W RRN3 13 76
YGR245C SDA1 22 14
YDR472W TRS31 7.5 22
YDR327W N/A
c 460 160
YOR262W N/A
b, c 9.8 13
aCDC14 and PRE1 were identified at both the 24 hr and 48 hr time points and
data for both time points is listed as ‘‘24 hr; 48 hr’’.
bHSF1 and YOR262W were identified at the 24 hr time point and all other genes
were identified at the 48 hr time point.
cORF not annotated in Saccharomyces Genome Database.
doi:10.1371/journal.pone.0023988.t002
Figure 2. Dox-induced repression of 19 essential yeast genes enhances BMV RNA replication. Total RNA extracts were obtained from
wild type R1158 and untreated and dox-treated (10 mg/ml) essential yeast strains expressing BMV 1a, 2a
Pol and RNA3. Accumulation of positive- and
negative-strand RNA3 and subgenomic RNA4 was detected by Northern blotting using probes specific for BMV RNA3 and RNA4. Equal loading of
total RNA was verified by probing for 18S rRNA. Values represent the mean of four independent experiments.
doi:10.1371/journal.pone.0023988.g002
Essential Genes and BMV RNA Replication
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inhibited ,1.5- to 8-fold in these strains (Fig. 3 and Table 5). In
addition to the severe inhibition of (+)RNA4 accumulation in
PTET-HSF1,P TET-PRE1, and PTET-RPT6,( 2)RNA3 was inhibited
5.5-, 1.8-, and 5.5-fold in these strains, respectively (Fig. 3 and
Table S6).
Interestingly, all five genes that inhibited BMV RNA replication
(ESS1, HSF1, JAC1, PRE1, and RPT6) perform cellular functions
that, in various ways, contribute to modulating host protein levels
(Table 4).
BMV 2a
Pol protein levels are affected in some dox-
repressed strains
One possible reason for altered RNA replication is deregulation
of viral protein accumulation. To test this, accumulation of BMV
RNA replication proteins 1a and 2a
Pol were assayed by Western
blotting. Addition of dox to growth medium had no detectable
effect on BMV 1a and 2a
Pol accumulation in the wild type strain
(Figs. 4 and 5). For 20 of 24 confirmed hits, BMV 1a levels in dox-
treated strains were comparable to their untreated sample (Figs. 4
and 5). However, in PTET-ADE13,P TET-DED1,P TET-PRE1 and
PTET-RPT6 dox-treated cells there was a detectable increase in 1a
compared to the untreated strains (Figs. 4 and 5). Moreover, BMV
2a
Pol levels were significantly increased in PTET-HSF1,P TET-PRE1
and PTET-RPT6 dox-treated strains (Fig. 5). In PTET-JAC1 dox-
treated cells, 2a
Pol levels were elevated in the absence of dox, but
reduced to near wild type levels in the presence of dox (Fig. 5).
These results suggest that, with the potential exception of HSF1,
PRE1 and RPT6, viral protein regulation is unlikely to be the cause
of altered viral RNA replication phenotypes upon depleting the
products of the implicated genes.
Discussion
We employed a high-throughput, systematic analysis of 741
dox-repressible essential yeast strains to identify 24 novel, essential
host factors that alter BMV RNA replication. Our previous
systematic analysis of ,4,500 non-essential yeast deletion strains
identified 99 genes that inhibited or enhanced BMV RNA
replication [9]. Collectively, we have analyzed ,93% of all yeast
genes (,5,800), and the 123 host genes identified to date that
affect BMV RNA replication represent 2.3% of the yeast genome.
As observed with tomato bushy stunt virus (TBSV) [38], another
positive strand RNA virus, BMV replication is affected, directly or
indirectly, by essential genes at a higher frequency (3.2%) than
non-essential genes (2.2%).
For multiple reasons, our studies to date likely underestimate the
number of host genes that contribute to BMV RNA replication.
,60% of non-essential yeast genes are genetically redundant,
meaning that the functions of many gene deletions are partially
compensated for by other genes [39,40]. Additionally, although
the dox-repressible library is a powerful tool for analyzing the
effects of essential genes on virus replication, over 70% of the
strains in this collection exhibit growth defects in the presence of
dox and 14% exhibit growth defects in the absence of dox [27].
Moreover, expressing viral components in some of these strains
resulted in no or poor growth, interfering with meaningful analysis
of these strains. Finally, in both the screens for non-essential genes
[9] and essential genes (here), virus dependence on some host
functions was likely masked by continuous expression of BMV
replication proteins and RNA templates, compared to natural
infections resulting from a single viral RNA template. This is
analogous to studies in which high multiplicity of infection
overcomes antiviral resistance in some cell lines [39,41]. The
lower confirmation rate for the 19 candidate genes that inhibited
BMV-directed Rluc expression may be because these primary
screen candidates included false positives arising from the
tendency of essential gene depletion to produce non-specific
inhibitory effects and greater variability in results, as is also noted
above in the Results section. Additionally, translation and protein
expression are the basis of our primary screen luciferase assays,
whereas secondary confirmation by Northern blotting analyzes
RNA levels normalized to 18S rRNA. Subtle differences (e.g.,
growth conditions) not controlled for by Fluc in the primary screen
or 18S rRNA in Northern analysis may also contribute to the
lower confirmation rate observed. Despite such limitations,
this study identified 24 novel, essential host genes from various
cellular pathways with potentially diverse roles in BMV RNA
replication.
Enhanced BMV RNA replication upon repression of an
essential gene suggests that, when present, the host factor con-
tributes to an inhibitory response in a cellular process/pathway
that competes with the virus. For example, of the 19 genes whose
repression stimulated BMV RNA replication, 9 genes (DHR2,
ECM16, NOP7, PWP1, RIO2, RPA43, UTP4, UTP18, YGR251W)
are functionally associated with ribosome biosynthesis (Table 4).
All of these genes perform or participate in ATP-dependent
processes and depleting products of the implicated genes may
result in an increased pool of energy and/or nucleotides available
to the virus (Fig. 2, Tables 3 and 4). Alternatively, depleting these
genes may alter the competition between viral and cellular
translation. UTP4 and UTP18 function in rRNA processing, a
cellular pathway that enhances TBSV replication (as shown by the
Table 3. Essential genes whose repression was confirmed to
enhance BMV RNA accumulation in secondary validation
testing.
ORF Gene
(+)RNA4 (average
% untreated) q-value
YJL069C UTP18 8336312 0.011
YNL207W RIO2 6356190 0.003
YKL018W SWD2 3896153 0.006
YOR204W DED1 282661 0.003
YPL124W SPC29 261693 0.006
YLR359W ADE13 2586126 0.034
YOR122C PFY1 232646 0.009
YOR340C RPA43 227676 0.010
YDL132W CDC53 222613 3.24E-04
YGR119C NUP57 194619 0.006
YMR128W ECM16 190641 0.011
YGR251W N/A
a 189645 0.014
YDR324C UTP4 180649 0.003
YLR196W PWP1 165641 0.011
YKL078W DHR2 161665 0.036
YGR103W NOP7 155621 0.011
YBR070C ALG14 153620 0.006
YGL044C RNA15 153616 0.003
YGR116W SPT6 152612 0.003
aORF not annotated in Saccharomyces Genome Database.
doi:10.1371/journal.pone.0023988.t003
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BMV RNA replication.
Depleting genes involved in processing cellular mRNA 39 ends
(RNA15), regulating transcription (SPT6), modulating cellular gene
expression (SWD2), and controlling nucleocytoplasmic trafficking
(NUP57) may increase the availability of ribosomes and/or alter
the levels of specific proteins, preferentially stimulating BMV RNA
replication (Fig. 2, Tables 3 and 4) by disrupting cellular pathways
that would compete with BMV RNA translation or replication
under wild type conditions. Thus, experimental depletion of these
genes is in some ways analogous to the global shutoff of host
mRNA pathways, employed by many mammalian viruses through
diverse mechanisms [42,43,44]. Additional studies are necessary to
define the role of these mRNA metabolism genes in BMV RNA
replication.
In previous studies, we have observed that significantly
disrupting the cell cycle and extended doubling times can non-
specifically increase BMV RNA levels per cell, apparently because
the virus has more time to accumulate RNA replication products
prior to cell division (unpublished data). To avoid such false
positives, we excluded from further analysis strains for which dox-
treatment significantly slowed cell division (see Results above).
Thus, although SPC29 and PFY1 encode proteins potentially
related to cell division (respectively a spindle pole body protein and
actin-binding protein) the doubling times of untreated and dox-
treated PTET-SPC29 and PTET-PFY1 cells were comparable and
likely do not account for the increased levels of BMV RNA4
observed (Fig. 2. and Table 3). Alternatively, disrupting the cell
cycle in PTET-SPC29- and/or PTET-PFY1-repressed cells may alter
cell cycle signal transduction pathways or the localization of
cellular factors that normally inhibit viral RNA replication.
Mutating general translation initiation factor DED1 severely
inhibits translation of BMV 2a
Pol from BMV genomic RNA2 in a
fashion dependent on specific sequences in the RNA2 59
noncoding region (NCR) [32]. Because the RNA2 59 NCR was
not present in the BMV expression constructs used in this study,
Table 4. Annotated functions of confirmed essential host genes effecting BMV RNA accumulation.
Gene
a Gene Description
a,b
Protein Homeostasis
ESS1 Peptidylprolyl-cis/trans-isomerase; regulates phosphorylation of the RNA polymerase II large subunit
HSF1 Trimeric heat shock transcription factor
JAC1 Hsp40/DnaJ family J-protein that functions with Hsp70 in Fe-S cluster biogenesis in mitochondria
PRE1 Beta 4 subunit of the 20S core of the 26S proteasome
RPT6 One of six ATPases of the 19S regulatory particle of the 26S proteasome
PFY1 Binds profilin, actin and phosphatidylinositol 4,5-bisphosphate; cytoskeleton organization
Translation
DED1 ATP-dependent DEAD-box RNA helicase, required for translation initiation of all yeast mRNAs
Trafficking
NUP57 Nucleoporin essential for trafficking nucleic acids, proteins, and RNA through the nuclear pore complex
Lipid synthesis
ALG14 Component of UDP-GlcNAc transferase required for dolichyl-linked oligosaccharide synthesis
Ribosome Biosynthesis
DHR2 DEAH-box ATP-dependent RNA helicase, required for 18S rRNA synthesis
ECM16 DEAH-box ATP-dependent RNA helicase specific to the U3 snoRNP, required for 18S rRNA synthesis
NOP7 Required for large ribosomal subunit maturation; required for exit from G0
PWP1 Protein with WD-40 repeats involved in rRNA processing
RIO2 Serine kinase involved in the processing of the 20S pre-rRNA into mature 18S rRNA
RPA43 RNA polymerase I subunit A43
UTP4 Subunit of U3-contaning complexes involved in production of 18S rRNA
UTP18 Possible U3 snoRNP protein involved in maturation of pre-18S rRNA
YGR251w Required for 18S rRNA maturation
mRNA Metabolism
RNA15 Component involved in the cleavage and polyadenylation of mRNA 39 ends
SPT6 Transcription elongation factor required for the maintenance of chromatin structure during transcription
SWD2 Required for methylation of histone H3 and RNA polymerase II transcription termination
Cell Cycle/DNA Maintenance
ADE13 Adenylosuccinate lyase involved in the purine nucleotide synthesis
CDC53 A scaffolding subunit (cullin) for multiple E3 ubiquitin-ligase complexes; regulates G1-S cell cycle progression
SPC29 Inner plaque spindle pole body (SPB) component; required for SPB duplication
aBold font indicates genes whose repression inhibits viral RNA accumulation; non-bold font indicates genes whose repression enhances viral RNA accumulation.
bBased on the Saccharomyces Genome Database at http://www.yeastgenome.org/.
doi:10.1371/journal.pone.0023988.t004
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the dox-repressed PTET-DED1 strain. However, we observed an
increase in RNA replication (Fig. 2 and Table 3), suggesting that
dox-repression of PTET-DED1 and global depletion of its gene
products may have an alternative effect(s) on viral RNA replication
compared to the previously analyzed ded1-18 point mutant [32].
For example, under our screen conditions, repressing PTET-DED1
may alter the production of viral or cellular proteins in ways that
favor increased viral RNA accumulation. Further studies are
necessary to define such potential additional role(s) for DED1 in
BMV RNA replication.
Reduced BMV RNA replication upon repression of an essential
gene suggests that, when present, the host factor directly or
indirectly facilitates viral RNA synthesis or accumulation.
Interestingly, the five genes whose depletion inhibited BMV
RNA replication (ESS1, HSF1, JAC1, PRE1, RPT6) have varied
roles in protein stability or activation. For example, a small but
reproducible (,20%) inhibition of BMV RNA replication resulted
upon dox-repression of PTET-ESS1, a peptidyl-prolyl cis-trans
isomerase (PPI) (Fig. 3 and Table 5). Changes in isomerase activity
can alter the structure, stability, or intracellular localization of
client proteins [45], and deleting or mutating PPIs has variable
effects on positive-strand RNA viruses [46,47,48,49]. For example,
knockdown of cyclophilin A and loss of its PPIase activity severely
inhibits hepatitis C virus replication [46,50,51]. Conversely,
siRNA-mediated knockdown of cyclophilin G mRNA stimulates
hepatitis c virus replication [49]. Collectively, these findings
suggest multi-faceted, complex roles for PPIs in positive-strand
RNA virus replication.
JAC1, a member of the Hsp40/DnaJ family of proteins, encodes
a specialized J-protein co-chaperone that assists Hsp70 in iron-
sulfur (Fe-S) cluster biogenesis [52,53]. Fe-S clusters are among the
most versatile protein co-factors in the cell and participate in
electron transfer, ribosome biogenesis, regulating gene expression
and enzyme activity, and nucleotide metabolism [54,55,56]. The
inhibition of BMV replication upon dox-repressing PTET-JAC1
(Fig. 3 and Table 5) may result from negatively affecting the
activation and/or function of one or more cellular or viral factors
required for BMV RNA replication. Previously, we showed that
YDJ1, another J-protein co-chaperone of Hsp70 and Hsp90, is
required to activate the BMV RNA replication complex, likely
through modulating BMV 2a
Pol folding or assembly into the
complex [26]. Dox-repression of another heat shock protein,
PTET-HSF1, inhibited BMV RNA replication by 84% (Fig. 3 and
Table 5). Thus, our data suggest that BMV utilizes multiple
members of the heat shock protein family to facilitate RNA
replication.
Dox-repressing PTET-PRE1, a 20S proteasome core component,
inhibited BMV RNA replication by 70% (Fig. 3 and Table 5).
Similarly, repressing PTET-RPT6, one of six ATPases of the 19S
regulatory particle of the 26S proteasome, resulted in an ,90%
reduction in BMV RNA replication (Fig. 3 and Table 5).
Additionally, BMV 2a
Pol accumulation increased significantly in
both PTET-PRE1 and PTET-RPT6 dox-repressed cells (Fig. 5).
These results are consistent with previous findings that multiple
non-essential ubiquitin-proteasome system components contribute
to BMV RNA replication and that cells lacking PRE9, the only
non-essential 20S proteasome component, also exhibit a substan-
tial increase in BMV 2a
Pol levels [9]. Our prior data show that
having a substantial excess of 2a
Pol shifts replication compartments
from small spherular compartments to double membrane layers,
but does not inhibit viral RNA replication [57]. Thus, the increase
in 2a
Pol accumulation in dox-repressed PTET-PRE1 and PTET-
RPT6 (Fig. 5) is not likely the cause of decreased RNA replication.
However, prior results do not exclude the possibility that PRE1
and RPT6 depletion might affect BMV RNA replication by
directly or indirectly modulating 2a
Pol localization, post-transla-
tional modification or interacting partners. The 26S proteasome
localizes predominantly to the nuclear envelope-ER network [58],
the site of BMV RNA replication [16,59], and numerous viruses
utilize the ubiquitin-proteasome system to facilitate infection or
replication [60,61,62,63,64,65]. Studies to define the specific
role(s) of the ubiquitin-proteasome system in BMV RNA
replication are ongoing.
With the exception of NUP57, RNA15, SPC29 and YGR251w,
each of the essential genes identified in this study have recognized
orthologs in Arabidopsis thaliana (http://www.arabidopsis.org/ and
Figure 3. Dox-induced repression of five essential yeast genes
inhibits BMV RNA replication. Total RNA extracts were obtained
from wild type R1158 and untreated and dox-treated (10 mg/ml)
essential yeast strains expressing BMV 1a, 2a
Pol and RNA3. Accumula-
tion of positive- and negative-strand RNA3 and subgenomic RNA4 was
detected by Northern blotting using probes specific for BMV RNA3 and
RNA4. Equal loading of total RNA was verified by probing for 18S rRNA.
Values represent the mean of four independent experiments.
doi:10.1371/journal.pone.0023988.g003
Table 5. Essential genes whose repression was confirmed to
inhibit BMV RNA accumulation in secondary validation
testing.
ORF Gene
(+)RNA4 (average
% untreated) q-value
YGL048C RPT6 1268 0.024
YGL073W HSF1 1664 0.004
YER012W PRE1 30613 0.024
YGL018C JAC1 57613 0.029
YJR017C ESS1 8165 0.024
doi:10.1371/journal.pone.0023988.t005
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genes could function in BMV RNA replication in its natural plant
hosts. For example, we have shown here that dox-repression of
Hsp70 cofactor JAC1 or heat shock protein transcription factor
HSF1 significantly inhibits BMV RNA replication. Arabidopsis
encodes 18 Hsp70 family members and Hsp70s have been shown
to affect the replication of other (+)RNA viruses in plants,
including TBSV and turnip mosaic virus [66,67].
Similarly, PRE1 (PBD1 and PBD2 in Arabidopsis) and RPT6
(RPT6a and RPT6b in Arabidopsis) are essential components of the
highly conserved 26S proteasome and recent results from our
laboratory show that BMV RNA replication in yeast and plant
cells depends critically on the ubiquitin-proteasome pathway (B.
Gancarz and P. Ahlquist, unpublished results) [9,68].
In summary, our high-throughput analysis of essential yeast
genes identified a diverse set of host factors that affect BMV RNA
replication and significantly expanded our knowledge of cellular
pathways utilized by BMV. Additional studies both in yeast and in
BMV’s natural plant hosts should reveal how these host factors
affect the virus and provide new insights to host cell function and
virus-host interactions. Although targeting some essential genes
may result in deleterious effects on cells or patients, focusing on the
relevant cellular pathways, rather than only individual genes, may
overcome such issues. For example, two of the essential genes with
the most substantial inhibitory effect on BMV RNA replica-
tion, PRE1 and RPT6, are proteasome components, while other
Figure 4. BMV 1a and 2a
Pol levels for dox-repressed essential yeast genes with enhanced BMV RNA replication. Accumulation of BMV
1a and 2a
Pol in wild type R1158 and untreated and dox-treated (10 mg/ml) essential yeast strains was measured by Western blot analysis. Total
proteins were extracted from equal numbers of yeast cells and analyzed by SDS/PAGE. Equal loading of total protein was verified by measuring
Pgk1p levels.
doi:10.1371/journal.pone.0023988.g004
Figure 5. BMV 1a and 2a
Pol levels for dox-repressed essential
yeast genes with inhibited BMV RNA replication. Accumulation
of BMV 1a and 2a
Pol in wild type R1158 and untreated and dox-treated
(10 mg/ml) essential yeast strains was measured by Western blot
analysis. Total proteins were extracted from equal numbers of yeast
cells and analyzed by SDS/PAGE. Equal loading of total protein was
verified by measuring Pgk1p levels.
doi:10.1371/journal.pone.0023988.g005
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previous screen). Proteasome inhibitors have antiviral activity
against multiple diverse viruses (including herpes simplex virus,
hepatitis B virus, and HIV, among others), have been through
multiple clinical trials, and are already approved for use in patients
for some purposes. Many of the genes identified function in
pathways utilized by other viruses and thus may present potential
cellular targets for developing broad-spectrum antivirals.
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